World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT03428503
Date of registration: 05/02/2018
Prospective Registration: No
Primary sponsor: Pamukkale University
Public title: Comparison of Efficacy of Intravenous Paracetamol and Dexketoprofen for Acute Traumatic Musculoskeletal Pain
Scientific title: Comparison of Efficacy of Intravenous Paracetamol and Dexketoprofen for Acute Traumatic Musculoskeletal Pain in the Emergency Department: A Double-Blinded, Randomized, Controlled Trial
Date of first enrolment: December 2015
Target sample size: 200
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT03428503
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Factorial Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Care Provider, Investigator).  
Phase:  Phase 4
Countries of recruitment
Turkey
Contacts
Name:     Atakan Yilmaz, MD
Address: 
Telephone:
Email:
Affiliation:  Pamukkale University
Key inclusion & exclusion criteria

Inclusion Criteria:

- Patients were eligible for inclusion if they were aged 18 years or older, 65 years or
younger

- Isolated traumatic musculoskeletal pain

- Patients who agree to work and receive the approval

- VAS (visual analog scale) score>5.

Exclusion Criteria:

- Patients with severe liver, kidney,pulmonary and cardiac heartfailure

- To be Pregnancy and breast-feeding

- Have received analgesics in the last 6hours

- Patients of childbearing age who are not using a birth control method.

- Patients with neurological deficits

- Patients with sciatica and back pain

- Patients with cardiac chest pain

- Patients with chronic pain

- Patients with pre-existing dexketoprofen and paracetamol-induced gastrointestinal
bleeding and perforation

- Patients with reflected pain

- Patients with neoplastic pain

- Patients with an allergy trait (paracetamol and dexketoprofen)

- Illiterates and patients with vision problems



Age minimum: 18 Years
Age maximum: 65 Years
Gender: All
Health Condition(s) or Problem(s) studied
Musculoskeletal Pain
Intervention(s)
Drug: Dexketoprofen
Drug: Paracetamol
Primary Outcome(s)
Decrement of the pain on VAS [Time Frame: Baseline and 60 minutes]
Secondary Outcome(s)
Secondary ID(s)
2015HZL031
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history